combretastatin has been researched along with Animal Mammary Carcinoma in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Elming, PB; Horsman, MR; Nielsen, PS; Wittenborn, TR | 1 |
Horsman, MR | 1 |
Bertelsen, LB; Busk, M; Bussink, J; Horsman, MR; Iversen, AB; Laustsen, C; Lok, J; Munk, OL; Nielsen, T; Stødkilde-Jørgensen, H; Wittenborn, TR | 1 |
Bertelsen, LB; Bohn, AB; Brems-Eskildsen, AS; Horsman, MR; Laurberg, T; Møller, BK; Nielsen, T; Stødkilde-Jørgensen, H; Wittenborn, T | 1 |
Breidahl, T; Horsman, MR; Maxwell, RJ; Nielsen, FU; Stødkilde-Jørgensen, H | 1 |
5 other study(ies) available for combretastatin and Animal Mammary Carcinoma
Article | Year |
---|---|
Tumors Resistant to Checkpoint Inhibitors Can Become Sensitive after Treatment with Vascular Disrupting Agents.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Bibenzyls; CTLA-4 Antigen; Diphosphates; Disease Progression; Drug Resistance, Neoplasm; Female; Immune Checkpoint Inhibitors; Male; Mammary Neoplasms, Animal; Mice; Mice, Inbred C3H; Neovascularization, Pathologic; Stilbenes; Treatment Outcome | 2020 |
Enhancing the radiation response of tumors but not early or late responding normal tissues using a vascular disrupting agent.
Topics: Animals; Antineoplastic Agents, Phytogenic; Bibenzyls; Female; Gamma Rays; Lung; Mammary Neoplasms, Animal; Mice; Mice, Inbred C3H; Neovascularization, Pathologic; Radiation-Sensitizing Agents; Skin; Urinary Bladder | 2017 |
The potential of hyperpolarized
Topics: Animals; Antineoplastic Agents, Phytogenic; Bibenzyls; Carbon Isotopes; Female; Magnetic Resonance Spectroscopy; Mammary Neoplasms, Animal; Mice; Mice, Inbred C3H; Neovascularization, Pathologic; Positron-Emission Tomography; Tissue Distribution | 2017 |
A combretastatin-mediated decrease in neutrophil concentration in peripheral blood and the impact on the anti-tumor activity of this drug in two different murine tumor models.
Topics: Animals; Bibenzyls; Carcinoma, Squamous Cell; Disease Models, Animal; Female; Flow Cytometry; Granulocytes; Humans; Mammary Neoplasms, Animal; Mice; Necrosis; Neovascularization, Pathologic; Neutrophils | 2014 |
Effects of combretastatin on murine tumours monitored by 31P MRS, 1H MRS and 1H MRI.
Topics: Animals; Antineoplastic Agents, Phytogenic; Bibenzyls; Drug Screening Assays, Antitumor; Energy Metabolism; Hydrogen; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Mammary Neoplasms, Animal; Mice; Necrosis; Phosphorus; Stilbenes | 1998 |